Research Article
Multidrug-Resistant Acinetobacter: Detection of ESBL, MBL, blaNDM-1 Genotype, and Biofilm Formation at a Tertiary Care Hospital in Eastern Nepal
Table 2
Antibiotic resistance profile of isolated Acinetobacter species.
| | Antibiotics (n = no. of resistant isolates) | Acb complex (a = 167) | A. lwoffii (a = 83) | A. hemolyticus (a = 38) | A. junii (a = 6) | A. radioresistens (a = 30) |
| | Piperacillin n = 213 (65.7%) | 143 (85.6%) | 29 (34.9%) | 25 (65.7%) | 3 (50%) | 13 (43.3%) | | Ampicillin + sulbactam n = 119 (36.7%) | 97 (58%) | 4 (4.8%) | 11 (28.9%) | 1 (16.6%) | 6 (20%) | | Ceftazidime + Clavulanic acid n = 234 (72.2%) | 149 (89.2%) | 35 (42.1%) | 30 (78.9%) | 2 (33.3%) | 18 (60%) | | Ceftazidime n = 235 (72.5%) | 150 (89.8%) | 36 (43.3%) | 30 (78.9%) | 2 (33.3%) | 17 (56.6%) | | Cefepime n = 241 (74.4%) | 155 (92.8%) | 35 (42.1%) | 30 (78.9%) | 3 (50%) | 18 (60%) | | Cefotaxime n = 239 (73.8%) | 157 (94%) | 32 (38.5%) | 31 (81.5%) | 2 (33.3%) | 17 (56.6%) | | Ceftriaxone n = 213 (65.7%) | 147 (88%) | 23 (27.7%) | 29 (76.3%) | 2 (33.3%) | 12 (40%) | | Imipenem n = 114 (35.2%) | 96 (57.4%) | 5 (6%) | 9 (23.6%) | 1 (16.6%) | 3 (10%) | | Amikacin n = 145 (44.7%) | 117 (70%) | 9 (10.8%) | 12 (31.5%) | 1 (16.6%) | 6 (20%) | | Ciprofloxacin n = 162 (50.0%) | 127 (76%) | 16 (19.2%) | 11 (28.9%) | 1 (16.6%) | 7 (23.3%) |
|
|
